COURSE
PHARMACEUTICAL POLICY AND HEALTH MARKET
Course Director:
Professor Igor Franceti? MD PhD
Hours
Total: 14 (Lectures - 8; Seminars – 6) ECTS: 2.1
Course Description
The purpose of the pharmacy services is to procure, distribute, control, and monitor the acquisition and use of drugs so that the patient drug therapy is appropriate, safe, and cost-effective, and that it meets the physicians', patients', and pharmacists' goals and expectations. Pharmacy is an information-, product-, and outcome-oriented profession charged by society with ensuring the safe and appropriate use of drugs.
Assessment
Written Examination
Recommended Readings
1. Mandi? D, Oreškovi? S, Franceti? I. Oral antibiotic prescription in ambulatory care in 1999 - A contribution to the development of methods for drug consumption and prescription surveillance monitoring. Collegium Antropol 25 (2): 459-465 Dec 2001
2. Franceti? I, Lasagna L, Weintrabum M, et al. Prescripton prices under the New York Generic Substituion Law. Ann Intern. Med 92(3): 419-423
3. Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials. Volume 1; WHO, Geneva 1997
4. An International Comparison of Pharmaceutical Prices. Osterreichisches Bundesinstitut fur Gesundheitswesen, Austrian Health Institute. Vienna, 1993
5. Essential Drugs and Other Medicines. Theme Paper for Discussion: Effective Drug Regulation, What Can Countries Do?; WHO, Geneva 16-19 March 1999
6. Joseph A. Cornell. Computers in Hospital Pharmacy Management, Fundamentals and Applications; An Aspen Publication, London 1983
7. Panos Kanavos. Financing Pharmaceuticals In Transition Economies; Croatian Medical Journal 1999; 40: 244-259
8. Ingrid Rosian, Claudia Habl, Sabine Vogler. Pharmaceuticals: Market Control in Nine European Countries; Osterreichisches Bundesinstitut fur Gesundheitswesen. Austrian Health Institute. Vienna; November, 1998
9. Ramesh Govindaraj. Croatian Pharmaceutical Sector – Issues and Options. Annex: Pharmaceutical Issues and Options. The World Bank
10. Mrazek MF. Pharmaceutical Pricing in Developing Countries: Issues of Access to Medicines. Expert Review of Pharmacoeconomics and Outcomes Research 2(1):89-96